US Patent Issued to OCUMENSION THERAPEUTICS (SUZHOU) on May 26 for "1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2" (Chinese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,469, issued on May 26, was assigned to OCUMENSION THERAPEUTICS (SUZHOU) Co. LTD. (Suzhou City, China).

"1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2" was invented by Wenyuan Qian (Shanghai), Hongjian Wang (Shanghai), Liang Tan (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a class of spleen tyrosine kinase (Syk) and vascular endothelial growth factor receptor 2 (VEGFR2) dual inhibitors. Specifically, it discloses a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing the compound, a m...